<DOC>
	<DOC>NCT00826514</DOC>
	<brief_summary>The purpose of this study is to determine whether tanezumab is effective in the treatment of pain associated with chronic prostatitis.</brief_summary>
	<brief_title>An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis</brief_title>
	<detailed_description />
	<mesh_term>Pelvic Pain</mesh_term>
	<mesh_term>Prostatitis</mesh_term>
	<criteria>Diagnosis of chronic prostatitis Male adults at least 18 years of age Moderate to severe chronic prostatitis, with an average pain score above a predefined level To use contraception. History of symptoms for less than 3 of the last 6 months History of recurrent urinary tract infections, or genitourinary cancer Use of finasteride or dutasteride within 6 months. History of hepatitis B, C or human immunodeficiency virus (HIV)</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Chronic Prostatis</keyword>
</DOC>